| Type 2 Diabetes Mellitus |
1 |
1 |
| Adolescent Medicine |
0 |
0.99 |
| Hypertension |
0 |
0.48 |
| Diabetic Microvascular Complications |
0 |
0.43 |
| Renal Disease |
0 |
0.38 |
| Type 1 Diabetes Mellitus |
0 |
0.32 |
| Lipids Management |
0 |
0.3 |
| Autonomic Neuropathy |
0 |
0.25 |
| Diabetic Nephropathy |
0 |
0.25 |
| Neuropathy |
0 |
0.25 |
| Obesity |
0 |
0.22 |
| Peripheral Neuropathy |
0 |
0.22 |
| Heart Failure (HF) |
0 |
0.21 |
| Child |
0 |
0.2 |
| Dyslipidemia |
0 |
0.2 |
| Retinopathy |
0 |
0.2 |
| Biliary Disease |
0 |
0.18 |
| Cardiovascular Risk Management |
0 |
0.16 |
| Kidney |
0 |
0.15 |
| Myocardial Infarction (MI) |
0 |
0.14 |
| Retinal Diseases |
0 |
0.13 |
| Diabetic Retinopathy |
0 |
0.12 |
| Congestive Heart Failure |
0 |
0.11 |
| High Density Lipoprotein (HDL) cholesterol |
0 |
0.11 |
| LDL Cholesterol |
0 |
0.11 |
| Antihypertensive Agents |
0 |
0.1 |
| Bone Density |
0 |
0.1 |
| Epidemic |
0 |
0.1 |
| Heart |
0 |
0.1 |
| Lipoproteins |
0 |
0.1 |
| Adherence |
0 |
0.09 |
| Femoral Neck |
0 |
0.09 |
| Spine |
0 |
0.09 |
| Cardiomyopathy |
0 |
0.07 |
| Fatty Liver |
0 |
0.07 |
| Liver Disease |
0 |
0.07 |
| Lumbar Spine |
0 |
0.07 |
| Non-Alcoholic Fatty Liver Disease |
0 |
0.07 |
| Polycystic Ovary Syndrome |
0 |
0.07 |
| Eating Disorders |
0 |
0.06 |